Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico
about
sameAs
Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trialsEffect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trialsFish oil: what the prescriber needs to knowEffect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine.Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oilMeta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in DepressionHeart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationAntioxidants for chronic kidney diseaseVitamin E supplementation for adults with diabetes mellitusOmega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitusAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesOmega 3 fatty acids for prevention and treatment of cardiovascular diseaseStereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in menRisks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic reviewEffect of supplemental vitamin E for the prevention and treatment of cardiovascular diseaseObservational versus experimental studies: what's the evidence for a hierarchy?Effects of some common food constituents on cardiovascular diseaseEvaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guidelineThe VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular diseaseVitamins C and E: beneficial effects from a mechanistic perspectiveOpening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular riskEfficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trialsMetabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteersNegative confounding in the evaluation of toxicity: the case of methylmercury in fish and seafoodVitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trialVitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trialOmega-3-acid Ethyl Esters (Lovaza) For Severe HypertriglyceridemiaShould patients with cardiovascular disease take fish oil?Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signalsThe relationship between dose of vitamin E and suppression of oxidative stress in humansJuice powder concentrate and systemic blood pressure, progression of coronary artery calcium and antioxidant status in hypertensive subjects: a pilot studyWhy do antioxidants fail to provide clinical benefit?A review of clinical trials in dietary interventions to decrease the incidence of coronary artery diseaseLong-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors.Debate: Should statin be used in patients with heart failure?Use of biological based therapy in patients with cardiovascular diseases in a university-hospital in New York CityReversibility of stress-echo induced ST-segment depression by long-term oral n-3 PUFA supplementation in subjects with chest pain syndrome, normal wall motion at stress-echo and normal coronary angiogramTriglyceride-rich lipoproteins as a causal factor for cardiovascular disease
P2860
Q21090716-1FAFF03A-1CAD-4786-ABFB-335600CFB7B8Q21092321-8164E4B3-A92F-4188-B6EE-365E2A9FA026Q21133673-7358310E-B4D9-44E3-8CC0-4DCDD87EE8FBQ21195667-80A56A32-0316-4E10-9D5B-109567676834Q21245073-4B5B1A66-1FA1-40D3-9DAF-7B426930BFFCQ21245691-DD4BC73B-92BC-42F8-987E-932FA2E053C3Q22305455-B9E7A670-D6C2-4BEA-93E7-0AE4DE100788Q22306356-CA0D3992-1E24-45EE-88B1-3B96564BABCBQ24198197-824BE7AB-7BEE-4EB8-9663-70EEABFD565BQ24200827-67A5D093-E0DA-4E47-ADFD-6B86BBAFFB7CQ24242688-EFF118B8-D568-4F22-8F62-07685C1A07F0Q24242944-038B5436-BDC1-4940-A957-CF0A3AF365B8Q24245810-FF9FD701-3C60-43F2-9BBB-6E339DFE8A52Q24297600-C83D258E-7F66-4A25-A161-8FAAD58EC6FEQ24532040-B83597B3-EC2D-486D-8C0B-8702C6B5B7E2Q24541608-05FBFA2D-18DA-4A35-96CB-79A08D824051Q24550510-9B6A49B8-9FC7-404D-94B4-F95DA493AD68Q24558950-2744D279-E05B-4C2A-BDC3-0C37B4F8AA62Q24605384-B4F698FC-6673-4B9E-BE68-34989EEA23FBQ24608464-6D47CCAC-9D45-4DDC-AB48-FF7171D8D109Q24613094-90F6EF8D-1E94-48AA-AD6F-541FE81ACDA2Q24617202-38C1EB72-B9A2-4903-84AA-867A802639E7Q24626884-232C4717-32DB-46B7-964B-33A1B24259E5Q24632223-E738C646-2E4A-49E8-B499-851B5D9BEB09Q24634434-AF600535-E977-4E4B-B8BF-5AC4DFD3D072Q24648766-73C380D3-4E8D-4EFF-8628-24BCF00FE417Q24652763-EC0E0A5F-DCA6-46F0-AE7B-4F25DCF83370Q24654699-2A665CA6-9E48-4F82-9503-CDCBFE1DCD85Q24658510-849F5115-5FFB-488C-A906-6F3EE937DB51Q24669570-B1D0770C-B73C-423C-AF0E-E6630D752239Q24673096-FBD086EB-A300-4E1D-8A28-C7B6F35A5042Q24680423-3BBCA7A9-815D-455A-92AB-F1FB297B39EFQ24685582-F96B5698-A2FF-44B2-B988-9C8A2FF4B7F5Q24792450-08DA5B28-6B91-4E9C-A3FB-A3130431D1B3Q24793178-0E584C35-57D2-4A55-9901-F12ACBDE3704Q24794281-84298110-56EB-4331-8434-FCA49AFB37DFQ24799305-FC9664D6-0378-4EF6-98F1-9097B2A53A68Q24803295-8088B8DC-35E3-44CC-B3E0-3147256A770EQ24805002-68463E1E-406C-4C29-95ED-990F8FC4EB88Q26745946-4DF395B5-D4A4-4531-BC2D-84E10A1BA39E
P2860
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Dietary supplementation with n ...... ivenza nell'Infarto miocardico
@ast
Dietary supplementation with n ...... ivenza nell'Infarto miocardico
@en
Dietary supplementation with n ...... ivenza nell'Infarto miocardico
@nl
type
label
Dietary supplementation with n ...... ivenza nell'Infarto miocardico
@ast
Dietary supplementation with n ...... ivenza nell'Infarto miocardico
@en
Dietary supplementation with n ...... ivenza nell'Infarto miocardico
@nl
altLabel
Dietary supplementation with n ...... of the GISSI-Prevenzione trial
@ast
Dietary supplementation with n ...... of the GISSI-Prevenzione trial
@en
prefLabel
Dietary supplementation with n ...... ivenza nell'Infarto miocardico
@ast
Dietary supplementation with n ...... ivenza nell'Infarto miocardico
@en
Dietary supplementation with n ...... ivenza nell'Infarto miocardico
@nl
P921
P1433
P1476
Dietary supplementation with n ...... of the GISSI-Prevenzione trial
@en
Dietary supplementation with n ...... ivenza nell'Infarto miocardico
@en
P356
10.1016/S0140-6736(99)07072-5
P407
P577
1999-08-01T00:00:00Z
1999-08-07T00:00:00Z